Hismanal®
Hismanal® was removed from the market by its manufacturer, Janssen Pharmaceutica, after many reports of adverse reactions to the drug. Since the drug's approval in 1988, new adverse reaction data has required a series of labeling changes and warnings. The company took this action after careful consideration of the antihistamine class, which includes multiple alternative medications.
Source: fda.gov
If you or a loved one has been harmed by Hismanal®, you may want to contact a Hismanal® attorney for more information.Attorney Search
Find a Defective Drug Attorney
Defective Drugs
News Alert
We will email you a news alert when Defective Drugs news article appears online.
Defective Drugs Questions
If you or a loved one has suffered harm as a result of the dangerous side effects associated with a defective drug, contact a qualified attorney today.